BUZZBERGThe leaderboard is ranked by Alpha Score, which weighs a speaker's average return, their number of calls, and reputation — a credibility rating of the source that can only raise a score, never lower it.Read the FAQ
Buy AEHR as a play on growing demand for wafer-level burn-in testing of AI/data center photonics chips; speaker views the post-earnings selloff as unjustified and sees it as an entry opportunity.
Buy AEHR as a play on growing demand for wafer-level burn-in testing of AI/data center photonics chips; speaker views the post-earnings selloff as unjustified and sees it as an entry opportunity.
Initiating long in SMR with a multi-month DCA plan; author cites personal underexposure to energy and belief that nuclear/uranium will recover as the core rationale.
Initiating long in SMR with a multi-month DCA plan; author cites personal underexposure to energy and belief that nuclear/uranium will recover as the core rationale.
Author names HIMS alongside OUST as a candidate for 1,000%+ upside in 12-24 months in direct response to a "next big bets" question, implying high-conviction multi-bagger potential.
Author names HIMS alongside OUST as a candidate for 1,000%+ upside in 12-24 months in direct response to a "next big bets" question, implying high-conviction multi-bagger potential.
Author discloses an ongoing, high-conviction bullish position in $TE, held through severe drawdowns (50-60% referenced in parent context); no specific catalyst restated beyond continued conviction.
Author discloses an ongoing, high-conviction bullish position in $TE, held through severe drawdowns (50-60% referenced in parent context); no specific catalyst restated beyond continued conviction.
Buy PLTR for long-term hold; author initiates a new position after years of avoiding it, citing continued execution, accelerating growth, and a valuation that is cheaper (though not cheap) relative to its historical range — drawing a parallel to holding NVDA through persistent "overvalued" criticism.
Buy PLTR for long-term hold; author initiates a new position after years of avoiding it, citing continued execution, accelerating growth, and a valuation that is cheaper (though not cheap) relative to its historical range — drawing a parallel to holding NVDA through persistent "overvalued" criticism.
Buy AMPG; author discloses a new long position initiated at $5.06/share and signals early-stage conviction with "just getting started," implying expectation of further upside from current entry.
Buy AMPG; author discloses a new long position initiated at $5.06/share and signals early-stage conviction with "just getting started," implying expectation of further upside from current entry.
Author discloses current long positions in LMND and OSCR, citing a disruption thesis against legacy insurance incumbents as the core rationale for holding both names.
Author discloses current long positions in LMND and OSCR, citing a disruption thesis against legacy insurance incumbents as the core rationale for holding both names.
caesarcapitalz has 28 trade ideas tracked on Buzzberg across 28 tickers since May 2026. Win rate 33% across 27 evaluated calls, average return -11.6%. Ranked #967 on the Buzzberg Alpha leaderboard. Most covered: AAOI, ASTS, ONDS.
#967Ranked Speaker
#967 of 1327 voices on Buzzberg